跳至主要内容
临床试验/DRKS00025133
DRKS00025133已完成未知

Study for the evaluation of a mobile application for independent cognitive training - effects on cognitive abilities and quality of life of patients with mild cognitive disorders - NeuroNation MED - Effect study (NeNaE)

Charité- Universitätsmedizin Berlin0 个研究点目标入组 288 人开始时间: 2021年11月5日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
288

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Arm 1 & 2 :
  • - Age = 18 years
  • - Existing diagnosis of mild cognitive impairment (ICD-10: F06.7)
  • - Mild cognitive impairment (TICS (Telephone Interview for Cognitive Status) >20 and < 33).
  • - Ability to consent
  • - Ability and experience in using a mobile device to use the app
  • - Able to understand instructions in German language
  • - Presence of a mobile device to use the app.
  • Arm 3 & 4 : Post-Covid.
  • - Age = 18 years
  • - Current diagnosis of mild cognitive disorder (ICD-10: F06.7) and post-Covid condition (ICD-10 U09.9) Diagnosis
  • - Capacity to consent
  • - Ability and experience in using a mobile device to use the app

排除标准

  • Exclusion criteria (all arms):
  • - Severe cognitive impairment (TICS <21).
  • - Presence of moderate or severe dementia
  • - Legal care
  • - Paresis of the dominant arm or hand
  • - Visual field defects (e.g., hemianopsia, quadranta-nopsia)
  • - Severe non-correctable visual impairment (unable to visually recognize app content)
  • - Severe aphasia that impairs instructional comprehension
  • - Use of other apps and software (training products) that provide cognitive training

研究者

相似试验